| apparent diffusion coefficient |
phenotype |
2 |
— |
ADC |
| appearance |
phenotype |
2 |
2 |
|
| appetite |
phenotype |
5 |
4 |
|
| Applied Biosystems |
drug |
8 |
3 |
|
| approach |
phenotype |
2 |
1 |
|
| approach system |
phenotype |
3 |
2 |
approach, approach behavior, approach circuit |
| APP-transgenic mice |
cohort |
2 |
2 |
|
| aprotinin |
drug |
3 |
1 |
|
| APV |
drug |
4 |
4 |
2-Amino-5-phosphonopentanoic acid, 2-amino-5-phosphonovaleric acid, APV (antagonist of NMDARs), NMDA receptor antagonist, NMDA receptor antagonist APV |
| Arabidopsis thaliana |
cohort |
4 |
2 |
ARATH |
| Ara-C |
drug |
2 |
2 |
Ara-C, C1648, Cytosine arabinoside, cytarabine, cytosine arabinoside |
| arachidonic acid |
drug |
3 |
— |
AA |
| ARC |
gene |
4 |
3 |
Arc, activity-regulated cytoskeletal protein complex |
| Arcturus Picopure Kit |
drug |
2 |
1 |
|
| arginine |
drug |
2 |
1 |
L-arginine |
| ARHGEF6 |
gene |
2 |
2 |
Rac/Cdc42 guanine nucleotide exchange factor 6 |
| ARIC |
cohort |
5 |
3 |
ARIC cohort, ARIC study, Atherosclerosis Risk in Communities |
| ARID4A |
gene |
2 |
2 |
AT-Rich Interaction Domain 4A |
| Army STARRS |
cohort |
2 |
2 |
Army STARRS cohort, Study to Assess Risk and Resilience in Servicemembers |
| ARND |
phenotype |
9 |
2 |
Alcohol-Related Neurodevelopmental Disorder |
